E. Reckziegel

E. Reckziegel

Auto-generated profile, based on publicly available information

E. Reckziegel

From the Departments of Radiology (A.K., L.M.V.) and Medical Genetics Services (E.R., L.B.J., J.A.M.S.), Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil; Departments of Neurology (M.C.F., T.J.R.R.) and Cosmic Rays and Chronology (T.J.R.R.), Universidade Estadual de Campinas, Campinas, Brazil; and Department of Internal Medicine (L.M.V., L.B.J.) and Postgraduate Program in Medicine: Medical Sciences (L.B.J.), Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2016 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
AKA. Klaes
A. Klaes
ERE. Reckziegel
E. Reckziegel
MFMarcondes C. França
Marcondes C. França
TRT. J. R. Rezende
T. J. R. Rezende
LVL. M. Vedolin
L. M. Vedolin
JSJ. A. Saute
J. A. Saute
BACKGROUND AND PURPOSE: Polyglutamine expansion spinocerebellar ataxias are autosomal dominant slowly progressive neurodegenerative diseases with no current treatment. MR imaging is the best-studied surrogate biomarker candidate for polyglutamine expansion spinocerebellar ataxias, though with conflicting results. We aimed to review quantitative central nervous system MR imaging technique findings in patients with polyglutamine expansion spinocerebellar ataxias and correlations with well-established clinical and molecular disease markers. MATERIALS AND METHODS: We searched MEDLINE, LILACS, and Cochrane data bases of clinical trials between January 1995 and January 2016, for quantitative MR imaging volumetric approaches, MR spectroscopy, diffusion tensor imaging, or other quantitative techniques, comparing patients with polyglutamine expansion spinocerebellar ataxias (SCAs) with controls. Pertinent details for each study regarding participants, imaging methods, and results were extracted. RESULTS: After reviewing the 706 results, 18 studies were suitable for inclusion: 2 studies in SCA1, 1 in SCA2, 15 in SCA3, 1 in SCA7, 1 in SCA1 and SCA6 presymptomatic carriers, and none in SCA17 and dentatorubropallidoluysian atrophy. Cerebellar hemispheres and vermis, whole brain stem, midbrain, pons, medulla oblongata, cervical spine, striatum, and thalamus presented significant atrophy in SCA3. The caudate, putamen and whole brain stem presented similar sensitivity to change compared with ataxia scales after 2 years of follow-up in a single prospective study in SCA3. MR spectroscopy and DTI showed abnormalities only in cross-sectional studies in SCA3. Results from single studies in other polyglutamine expansion spinocerebellar ataxias should be replicated in different cohorts. CONCLUSIONS: Additional cross-sectional and prospective volumetric analysis, MR spectroscopy, and DTI studies are necessary in polyglutamine expansion spinocerebellar ataxias . The properties of preclinical disease biomarkers (presymptomatic) of MR imaging should be targeted in future studies.